Language selection

Government of Canada / Gouvernement du Canada

Search

COVID-19 vaccination in Canada

Doses distributed Doses administered Vaccination coverage Understanding the data

Older versions of this report are available on the archived reports page.

Doses administered

This page provides information on the number of COVID-19 vaccine doses that have been administered in Canada by jurisdiction, dose number and vaccine product. The number of vaccine doses administered is not the same as the number of people vaccinated.

We update information on the number of COVID-19 doses administered across Canada at different times:

On this page

Key updates as of {MMM DD, YYYY}

{Number of doses delivered}

total doses administered as
reported since December 14, 2020

We update this number every weekday. Most provinces and territories do not update their numbers every day (see data sources). Information is subject to change and may differ from provincial and territorial reports (see limitations).

As most jurisdictions have reduced or stopped their regular update on doses administered on their website, the information on the number of doses administered the previous day has been removed.

About COVID-19 vaccines and vaccination

Vaccination programs, primary series and booster doses

Vaccination programs

  • COVID-19 vaccination began in Canada on December 14, 2020.
  • 7 COVID-19 vaccines are currently approved for use in Canada.
  • The National Advisory Committee on Immunization’s (NACI) recommendations on the use of COVID-19 vaccines can be found in the latest NACI statements.
  • People 6 months and older without contraindications to the vaccine are currently eligible for COVID-19 vaccination.

Primary series

2-dose vaccines

For all 2-dose vaccines:
  • People who have received only 1 dose are considered partially vaccinated.
  • People who have received both doses are considered to have completed their primary vaccine series (referred to as "fully vaccinated" in previous reports).
  • Moderately to severely immunocompromised people who have received both doses and an additional dose of an mRNA vaccine are considered to have completed their primary vaccine series.

1-dose vaccine

For 1-dose vaccines:
  • People who have received only 1 dose are considered to have completed their primary vaccine series.
  • Moderately to severely immunocompromised people who have received 1 dose and an additional dose of an mRNA vaccine are considered to have completed their primary vaccine series.

Booster doses

A booster dose received after the primary series restores or improves protection against COVID-19.

NACI recommends a booster dose of an mRNA vaccine or Novavax Nuvaxovid® at least 6 months after the primary series is completed for members of the following populations.

  • A booster should be offered to:
    • adults 18 and older
    • adults living in long-term care homes for seniors or other congregate living settings that provide care for seniors
    • people who completed their series with only viral vector vaccines (the AstraZeneca Vaxzevria/COVISHIELD or Janssen COVID-19 vaccines)
    • adults in or from First Nations, Inuit, and Métis communities
    • all frontline health care workers who have direct in-person contact with patients
    • adolescents 12 to 17:
      • with an underlying medical condition at high risk of severe illness due to COVID-19 (including those who are immunocompromised and who received a 3-dose primary series)
      • who are residents of congregate living settings (e.g., shelters, group homes, quarters for migrant workers, correctional facilities)
      • who belong to racialized and/or marginalized communities disproportionately affected by COVID-19
  • A booster may be offered to:
    • adolescents 12 to 17

NACI recommends that jurisdictions prepare for the rapid deployment of a second COVID-19 vaccine booster dose program prioritizing certain populations.

Local information

For local information on doses administered, please see your province’s or territory’s COVID-19 vaccination website.

Doses administered: updates from provincial and territorial websites Access and download the national COVID-19 vaccine administration data in .csv format

Altogether, {Total doses administered} vaccine doses have been administered as of {MMM DD, YYYY}.

Figure 1. Cumulative number of COVID-19 vaccine administered in Canada by jurisdiction, as of DD MMM YYYY HH PM

Hover over or select a portion of the map to see the cumulative number of COVID-19 vaccine doses administered in Canada and each jurisdiction over time.

The cumulative number of COVID-19 vaccine doses {administered/distributed} in Canada was {1 000 / 0.1%} as of MMM DD, YYYY.
Access and download the national COVID-19 vaccine administration data in .csv format

Note: This information is based on the most current data available at the time of reporting. Green bars indicate the reported cumulative number of doses administered as of that date while grey bars are used for days where no data was reported. Due to differences in when provincial and territorial partners update their data, comparisons over time and between provinces and territories should be interpreted with caution (see data sources). Information is subject to change and may differ from provincial and territorial reports depending on when data is updated (see limitations).

Figure 1: Text description

Cumulative number of COVID-19 vaccine doses administered in Canada by jurisdiction as of MMM DD, YYYY

Doses administered: Reports from provinces and territories Access and download the national COVID-19 vaccine administration databy dose number and report week in .csv format

Information on doses administered by dose number and vaccine product is provided by provinces and territories every 4 weeks.

Figure 2. Number of COVID-19 vaccine doses administered in every 4 weeks by dose number, MMM DD, YYYY

Hover over or select a bar to see the number of doses administered by dose number and report week.

Figure 2. Number of COVID-19 vaccine doses administered in Canada every 4 weeks by dose number and jurisdiction, {MMM DD, YYYY}

Figure 2: Text description

Table 1. Cumulative number of COVID-19 vaccine doses administered in by vaccine product and dose number, as of MMM DD, YYYY

Vaccine product Total doses Dose 1 Dose 2 Dose 3 Dose 4 Dose 5+

Figure 3. Vaccine product breakdown of COVID-19 vaccine doses administered in by dose number, as of MMM DD, YYYY Access and download the national COVID-19 vaccine administration databy dose number and report week in .csv format

Hover over or select a bar to see the cumulative percentage of doses administered by dose number and vaccine product. Click on a legend element to add or remove the corresponding bars from the graph.

Figure 3. Vaccine product breakdown of COVID-19 vaccine doses administered in Canada by dose number, as of MMM DD, YYYY

Figure 3: Text description
Week ending Jurisdiction Vaccine product Total doses Dose 1 Dose 2 Dose 3 Dose 4 Dose 5+

Suggested citation

Public Health Agency of Canada. Canadian report on COVID-19 vaccine doses administered. Ottawa: Public Health Agency of Canada; MMM DD, YYYY. https://health-infobase.canada.ca/covid-19/vaccine-administration/

Related links

For health professionals

Did you find what you were looking for?

What was wrong?

Answers to frequently asked questions can be found in the Understanding the data section!

(Don’t include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Thank you for your feedback

Date modified: